CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU ...Middle East

News by : (PR Newswire) -

LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for market authorization of Oczyesa®, octreotide subcutaneous depot (CAM2029),...

Read More Details
Finally We wish PressBee provided you with enough information of ( CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU )

Also on site :

Most Viewed News
جديد الاخبار